Medical and Pharmaceutical Johnson & Johnson may bankrupt a subsidiary to pay USD$6.9B talcum cancer settlements J&J plans to place a subsidiary into bankruptcy if at least 75 per cent of the talc claimants vote for its settlement proposal Joseph MortonAugust 28, 2024
The weed wire CannTrust moves to reinstate licences, appoints new CEO In the wake of the biggest scandal in corporate cannabis to date, the company is also preparing for incoming litigation Nick LabaFebruary 14, 2020